Diamond Biofund Inc. (TPE:6901)
Taiwan · Delayed Price · Currency is TWD 16.40
-0.60 (-3.53%)
Feb 2, 2026, 1:35 PM CST
Diamond Biofund Revenue
Diamond Biofund had revenue of -122.09M TWD in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to -1.70B. In the year 2024, Diamond Biofund had annual revenue of -2.23B.
Revenue (ttm)
-1.70B
Revenue Growth
n/a
P/S Ratio
-8.53
Revenue / Employee
-51.44M
Employees
33
Market Cap
14.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | -2.23B | 210.73M | - |
| Dec 31, 2023 | -2.44B | -3.46B | - |
| Dec 31, 2022 | 1.02B | -2.05B | -66.85% |
| Dec 31, 2021 | 3.06B | -3.44B | -52.88% |
| Dec 31, 2020 | 6.50B | 6.80B | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cathay Financial Holding | 1.04T |
| Fubon Financial Holding | 928.60B |
| CTBC Financial Holding | 530.41B |
| Mercuries & Associates Holding | 150.49B |
| Mega Financial Holding | 74.88B |
| Central Reinsurance | 22.42B |
| Taiwan Fire & Marine Insurance | 7.28B |
| Concord Securities | 3.24B |